We are live on ! Find out more
TI

tru Independence Portfolio holdings

AUM $202M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+16.99%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
–
AUM
$691K
AUM Growth
+$78K
Cap. Flow
+$226M
Cap. Flow %
32,646.26%
Top 10 Hldgs %
41.04%
Holding
960
New
207
Increased
181
Reduced
170
Closed
53

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$61.5M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$54.4M
3
IUSG icon
iShares Core S&P US Growth ETF
IUSG
+$28.9M
4
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$16.7M
5
GLD icon
SPDR Gold Trust
GLD
+$9.38M

Top Sells

Rank Stock Value
1
FBT icon
First Trust NYSE Arca Biotechnology Index Fund
FBT
+$10.7M
2
GIS icon
General Mills
GIS
+$5.39M
3
MSFT icon
Microsoft
MSFT
+$3.32M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$3.24M
5
ENR icon
Energizer
ENR
+$2.86M

Sector Composition

Rank Sector Weight
1 Energy 28.66%
2 Technology 9.15%
3 Healthcare 7.9%
4 Financials 6.09%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PH icon
651
Parker-Hannifin
PH
$125B
$7 ﹤0.01%
40
– –
RY icon
652
Royal Bank of Canada
RY
$291B
$7 ﹤0.01%
100
– –
SNAP icon
653
Snap
SNAP
$7.32B
$7 ﹤0.01%
300
– –
SRVR icon
654
Pacer Data & Infrastructure Real Estate ETF
SRVR
$379M
$7 ﹤0.01%
+200
New +$6.74K
STKL
655
DELISTED
SunOpta
STKL
$7 ﹤0.01%
+106
New +$375
SWK icon
656
Stanley Black & Decker
SWK
$14.2B
$7 ﹤0.01%
51
+20
+65% +$2.41K
TU icon
657
Telus
TU
$16B
$7 ﹤0.01%
400
– –
VRTX icon
658
Vertex Pharmaceuticals
VRTX
$121B
$7 ﹤0.01%
24
– –
VTR icon
659
Ventas
VTR
$48.9B
$7 ﹤0.01%
+200
New +$6.61K
MRO
660
DELISTED
Marathon Oil Corporation
MRO
$7 ﹤0.01%
1,210
– –
EVA
661
DELISTED
Enviva Inc.
EVA
$7 ﹤0.01%
200
– –
EGIO
662
DELISTED
Edgio, Inc. Common Stock
EGIO
$7 ﹤0.01%
+25
New +$5.55K
EGIF
663
DELISTED
Eagle Growth and Income Opportunities Fund
EGIF
$7 ﹤0.01%
500
– –
A icon
664
Agilent Technologies
A
$39.1B
$6 ﹤0.01%
67
– –
BKR icon
665
Baker Hughes
BKR
$56.8B
$6 ﹤0.01%
400
– –
BLUE
666
DELISTED
bluebird bio
BLUE
$6 ﹤0.01%
8
– –
CNC icon
667
Centene
CNC
$31.3B
$6 ﹤0.01%
102
– –
CRSP icon
668
CRISPR Therapeutics
CRSP
$4.58B
$6 ﹤0.01%
+89
New +$5.2K
ETN icon
669
Eaton
ETN
$157B
$6 ﹤0.01%
75
+27
+56% +$2.22K
HPQ icon
670
HP
HPQ
$23.5B
$6 ﹤0.01%
369
+3
+0.8% +$48
ICMB icon
671
Investcorp Credit Management BDC
ICMB
$11.3M
$6 ﹤0.01%
1,800
-13
-0.7% -$50
ISRG icon
672
Intuitive Surgical
ISRG
$121B
$6 ﹤0.01%
33
– –
LTRN icon
673
Lantern Pharma
LTRN
$35.1M
$6 ﹤0.01%
+500
New +$6.46K
NDAQ icon
674
Nasdaq
NDAQ
$51.5B
$6 ﹤0.01%
150
– –
NEGG icon
675
Newegg Commerce
NEGG
$296M
$6 ﹤0.01%
+58
New +$4.6K
25 26
27
28 29

Similar funds

4FG
4Thought Financial Group Syosset, New York $202M AUM 11.53% 1-Year Est. Return
BFA
Brendel Financial Advisors Hanover, New Hampshire $202M AUM 37.99% 1-Year Est. Return
PCMK
Paragon Capital Management (Kansas) Overland Park, Kansas $202M AUM 26.44% 1-Year Est. Return
CWM
CarsonAllaria Wealth Management Glen Carbon, Illinois $202M AUM 15.75% 1-Year Est. Return
AFWM
Arta Finance Wealth Management Mountain View, California $202M AUM
HWMO
Heritage Wealth Management (Ohio) Cincinnati, Ohio $202M AUM 23.85% 1-Year Est. Return
PCM
Pointe Capital Management Grosse Pointe Farms, Michigan $202M AUM 17.2% 1-Year Est. Return
BSA
Bull Street Advisors Savannah, Georgia $202M AUM 11.06% 1-Year Est. Return

tru Independence's Q2 2020 Portfolio in Review

As of Q2 2020, tru Independence held 960 positions worth $691K, up 13% from $613K the previous quarter. Its ten largest holdings account for 41% of the portfolio.

tru Independence deployed $226M of net new capital in Q2 2020, opening 207 new positions and adding to 181 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,027,572 shares worth $19.

By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 2.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was First Trust NYSE Arca Biotechnology Index Fund, an estimated $10.7M trimmed.

  • tru Independence's largest Q2 2020 buy was Bristol-Myers Squibb: 1,027,572 shares worth $19.
  • tru Independence added most to SPDR Gold Trust in Q2 2020, an estimated $9.38M increase.
  • tru Independence's biggest Q2 2020 reduction was First Trust NYSE Arca Biotechnology Index Fund, cutting an estimated $10.7M.
  • tru Independence fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, selling an estimated $49.3K.
  • tru Independence's ten largest holdings make up 41% of its $691K portfolio in Q2 2020.
  • tru Independence opened 207 new positions and closed 53 in Q2 2020.
  • tru Independence's portfolio value rose 13% quarter-over-quarter to $691K.

Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.